In #children with newly diagnosed #ImmuneThrombocytopenia #ITP requiring pharmacologic therapy, #eltrombopag demonstrated superior performance compared with standard therapy, resulting in a sustained #platelet response of 65% vs. 35%: https://ow.ly/GGa350Yf9aM
#PediatricHematology #HemeSky
🩸More insights on emerging therapies & future directions in Inherited Bone Marrow Failure Syndromes
#AndrogenTherapy #Danazol #Telomeres #BoneMarrowFailure #IBMFS #Eltrombopag #ClonalEvolution #CD117 #Hematopoiesis #StemCellTherapy #Hematology #ClinicalUpdates #MedEd #HEMEHUB
Image showing a PICO summary for: #Eltrombopag for Newly Diagnosed Pediatric Immune Thrombocytopenia Requiring Treatment: The PINES Randomized Clinical Trial by Shimano et al. featured in the Transfusion Evidence Alert - December 2025
From the #Transfusion Evidence Alert:
#Eltrombopag for Newly Diagnosed Pediatric Immune Thrombocytopenia Requiring Treatment: The PINES Randomized Clinical Trial
by Shimano et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
En pacientes pediátricos con trombocitopenia inmune de diagnóstico reciente que requieren tratamiento farmacológico, eltrombopag mejora la respuesta plaquetaria sostenida #eltrombopag #thrombocytopenia jamanetwork.com/journals/jam...
#Medsky🧪 #pedsky #pharmasky The Pediatric ITP Newly Diagnosed Patients Eltrombopag vs. Standard Therapy (PINES) trial showed that #eltrombopag was significantly more effective at producing a sustained platelet response than standard 1st line therapies for children with newly diagnosed ITP
Elopag 50 mg (Eltrombopag) is an oral medication used to treat low platelet counts in conditions like chronic immune, aplastic anemia, and hepatitis C-related thrombocytopenia by stimulating platelet production.
#Elopag50mg #Eltrombopag #OnlineMedicine #Oncology #Health
jnspharma.com/product/elop...
